Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study

Sohn S, Schöffski O, Prinz JC, Reich K, Waldorf K, Augustin M (2006)


Publication Type: Journal article

Publication year: 2006

Journal

Book Volume: 212

Pages Range: 137-144

DOI: 10.1159/000090654

Abstract

Abstract

Background: There is little information concerning the costs of psoriasis and patients’ quality of life (QoL) in Germany. Objective: To obtain data on the annual costs and QoL(to follow in a further publication) of patients with moderate to severe plaque psoriasis. Methods: Between October 2003 and February 2004, six office-based dermatologists and eight dermatology outpatient departments retrospectively documented cost-of-illness data from a societal cost perspective in 184 patients over a 12-month period. Patients were stratified into three subgroups according to their treatment scheme. Results: Mean total costs amounted to € 6,709 per patient and year. The mean PASI score was 18.2 and PBSA 28.9%. Annual costs were highest with € 8,831 in high-need patients. They also showed the highest PASI score (22.2). Conclusion: Moderate to severe plaque psoriasis is associated with tremendous costs, particularly in patients not adequately controlled by conventional therapies, while the outcomes of patients were unsatisfactory.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Sohn, S., Schöffski, O., Prinz, J.C., Reich, K., Waldorf, K., & Augustin, M. (2006). Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study. Journal der Deutschen Dermatologischen Gesellschaft, 212, 137-144. https://dx.doi.org/10.1159/000090654

MLA:

Sohn, Stefan, et al. "Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness Study." Journal der Deutschen Dermatologischen Gesellschaft 212 (2006): 137-144.

BibTeX: Download